Rosetta Genomics Ltd.
ROSG
ROSG was delisted on the 21st of May, 2018.
11 hedge funds and large institutions have $1.4M invested in Rosetta Genomics Ltd. in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
20% more capital invested
Capital invested by funds: $1.16M → $1.4M (+$234K)
8% less funds holding
Funds holding: 12 → 11 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $35K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highlander Capital Management
Short Hills,
New Jersey
|
+$164K |
| 2 |
ICAS
Investors Capital Advisory Services
Lynnfield,
Massachusetts
|
+$73.9K |
| 3 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$71.3K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$10.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$770 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$83.1K |
| 2 |
SIM
Spark Investment Management
New York
|
-$70K |
| 3 |
Morgan Stanley
New York
|
-$15.1K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$15K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$8.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Highlander Capital Management
Short Hills,
New Jersey
| $706K | +$164K | +3,835 | +28% |
|
|
2
Morgan Stanley
New York
| $192K | -$15.1K | -354 | -7% |
|
3
California Public Employees Retirement System
Sacramento,
California
| $172K | – | – | – |
|
|
VKH
4
Virtu KCG Holdings
New York
| $71K | -$8.6K | -201 | -10% |
|
|
ICAS
5
Investors Capital Advisory Services
Lynnfield,
Massachusetts
| $70K | +$73.9K | +1,729 | New |
|
|
RCM
6
Rotella Capital Management
Bellevue,
Washington
| $68K | +$71.3K | +1,667 | New |
|
|
7
Millennium Management
New York
| $43K | -$83.1K | -1,943 | -65% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $39K | +$770 | +18 | +2% |
|
|
9
Group One Trading
Chicago,
Illinois
| $32K | +$10.2K | +239 | +44% |
|
10
Wells Fargo
San Francisco,
California
| $3K | -$3.59K | -84 | -50% |
|
11
Citigroup
New York
| $3K | -$642 | -15 | -15% |
|
|
SIM
12
Spark Investment Management
New York
| – | -$70K | -1,917 | Closed |
|
|
13
Creative Planning
Overland Park,
Kansas
| – | -$15K | -417 | Closed |
|
|
AIG
14
American International Group
New York
| – | -$1.85K | -50 | Closed |
|
ROSG Hedge Fund Activity: Q2 2015 in Review
11 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q2 2015, worth a combined $1.4M — up 20% from $1.16M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ROSG and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 3 added.
The largest buyer was Highlander Capital Management, adding an estimated $164K. The largest seller was Millennium Management, cutting an estimated $83.1K.
- 11 institutional investors held Rosetta Genomics Ltd. (ROSG) as of Q2 2015, down from 12 in Q1 2015.
- Funds reported $1.4M of Rosetta Genomics Ltd. stock for Q2 2015, up 20% quarter-over-quarter.
- 2 funds opened new Rosetta Genomics Ltd. positions in Q2 2015 and 3 closed out, a net change of -1 holder.
- The largest Rosetta Genomics Ltd. buyer in Q2 2015 was Highlander Capital Management, an estimated $164K added.
- The largest Rosetta Genomics Ltd. seller in Q2 2015 was Millennium Management, an estimated $83.1K sold.
Based on aggregated 13F filings for Q2 2015.